Expert Interview
A Second Look: Discussing Pfizer’s Emerging PD-1 × VEGF Bispecific Program (PF-4404) for NSCLC
Ticker(s): PFEDr. Xiuning Le - MD, PhD MD Anderson Cancer Center
Associate Professor and Deputy Section Chief, Department of Thoracic/Head & Neck Medical Oncology, Division of Internal Medicine (MD Anderson Cancer Center)
- Actively manages 50+ newly diagnosed patients with oncogene-driven lung cancers, particularly those with EGFR-mutant and MET exon 14 skipping non-small cell lung cancer, including through leading multiple clinical trials in these populations.
Leads principal investigator roles on numerous clinical trials targeting resistance mechanisms and novel therapies in lung cancer, including trials contributing to targeted therapy development with research focus on cancer genomics, precision oncology, resistance mechanisms to targeted and immunotherapies, and translational cancer research.
Are You Interested In These Questions?
Slingshot Insights Explained
- Call Date
- Dec 30, 2025
- Call Time
- 03:00 PM EST
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
